Comprehensive End-of-Life Care
Comprehensive End-of-Life Care Jennifer Shin, Jennifer Temel INTRODUCTION Comprehensive end-of-life (EOL) care is an essential component of oncology. While we aim to cure as many patients as possible, many of…
Comprehensive End-of-Life Care Jennifer Shin, Jennifer Temel INTRODUCTION Comprehensive end-of-life (EOL) care is an essential component of oncology. While we aim to cure as many patients as possible, many of…
Metastatic Prostate Cancer Matthew R. Smith INCIDENCE Prostate cancer is the most commonly diagnosed cancer in men and a leading cause of cancer death. In the United States, there were…
Pain Management Juliet Jacobsen, Vicki Jackson INTRODUCTION Cancer causes pain. Although studies give varying results, even the most conservative studies report that at least 20% of patients have pain at…
Immunology of Hematopoietic Stem Cell Transplantation Srinivas Viswanathan, Yi-Bin Chen Hematopoietic stem cell transplantation (HSCT) has wide applications in the treatment of hematologic malignancies, congenital and acquired disorders of hematopoiesis,…
Natural Products: Bleomycin and Trabectedin Bruce A. Chabner Natural product research has yielded many active anticancer compounds acting as inhibitors of topoisomerases (Chapter 4) and as antimitotics (Chapter 4). Others,…
Thyroid Cancer Lori J. Wirth, Tito Fojo Thyroid cancer is the most common endocrine malignancy with an estimated 60,220 cases to be diagnosed in the United States in 2013 (1)….